It is widely used to reduce the duration of febrile neutropenia following cytotoxic chemotherapy[17] and lymphopenia in patients with coronavirus disease 2019.[18] Several previous studies have demonstrated that G-CSF could also be used as an infectious biomarker. Here, CSF3 is linked to glycogen storage disease VI.